期刊文献+

ARMS实时PCR和MALDI-TOF-MS进行K-ras基因分型 被引量:1

Genotyping of K-ras Alleles by ARMS Real-time PCR and MALDI-TOF-MS
下载PDF
导出
摘要 [目的]建立K-ras基因12位密码子第一、二位点基因分型的研究模型。[方法]采用ARMS实时PCR和MALDI-TOF-MS两种方法,以自行构建的质粒DNA为模板,建立K-ras基因12位密码子第一、二位点基因分型的研究模型。[结果]在相同的扩增条件下,采用ARMS实时PCR方法,第一个位点的野生型和突变型的ΔCt值至少为,但第8二个位点野生型和突变型的ΔCt值仅为1~2左右。第二个位点改用MALDI鄄TOF-MS分型方法,采用一条公用引物和dATP,ddTTP,ddCTP和ddGTP的混和物,12密码子第二位点基因分型可以准确检测。[结论]ARMS实时PCR方法分析速度快,操作简便,但它需要合适的反应条件及高质量模板。MALDI-TOF-MS分型方法虽然步骤较多,但准确度高,反应体系稳定并具有高通量潜力。 To establish a research model for genotyping the first and second position of codon 12 of K-ras genotype. ARMS real-time PCR and MALDI-TOF-MS methods were used to screen K-ras genotype of the first and second position of codon 12 from the man-made plasmid templates DNAs. ΔCt value between wild-type and the mutants were at least 8 cycles for the first poisition of codon 12,but only 1~2 cycle for the second site by using ARMS real-time PCR with allele-specific primers. The second position was further analyzed by the MALDI-TOF-MS method using one common primer in combination with dATP, ddTTP, ddCTP and ddGTP. Different genotypes at second position of codon 12 were detected accuratly. [Conclusions] ARMS real-time PCR genotyping is faster and more convenient, but it needs a suitable reaction conditions and high -quality templates. MALDI-TOF-MS method is more time-consuming, but it has characteristic of high accuracy, high stability, and high-throughput.
出处 《中国肿瘤》 CAS 2005年第4期256-260,共5页 China Cancer
基金 福建省自然科学基金重点项目(No.C0220002)
关键词 基质辅助激光解吸飞行时间质谱 扩增阻碍突变系统方法 实时PCR 基因分型 K-RAS基因 基因突变 MALDI-TOF-MS ARMS real-time PCR genotyping K-ras gene gene mutation
  • 相关文献

参考文献14

  • 1袁平,孙孟红,张锦生,朱雄增.中国人大肠癌K-ras基因突变的研究[J].临床与实验病理学杂志,2000,16(6):464-466. 被引量:20
  • 2Lengauer C, Ennech WK, Vogelstein B. Genetic instabilities in human cancers[J]. Nature, 1998, 396(17): 643-649.
  • 3Gertig DM, Hunte DJ. Genes and environment in the etiology of colorectal cancer[J]. Cancer Biology, 1998, 8:285-298.
  • 4Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal tumor development [J].New England Medicine, 1988, 319: 525-532.
  • 5Kimura W, Zhao B, Futakawa N. Significance of K-ras codon 12 piont mutation in panereatic juice in the diagnosis of carcinoma of the pancreas [J]. Hepatogas-troenterology, 1999,46(25):532-539.
  • 6Claytonl SJ, Scott FM, Walker J, et al. Comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification[J]. Clinical Chemistry,2000,46:1929-1938.
  • 7Donohoe GG, Laaksonen M, Pulkki K, et al. Rapid single-tube screening of the C282-Y hemochromatosis mutation by real-time multiplex allele-specific PCR without fluorescent probes[J]. Clin Chem,46(10): 1540-1547.
  • 8Hahner S, Kostrzewa M, Wenzel T, et al. Strategies for SNP genotypingby mass spectrometry [J]. International Congress Series, 2003,1239:11-16.
  • 9Bonka T, Humenya A, Sutterb C, et al. Molecular diagnosis of familial adenomatous polyposis (FAP): Genotyping of adenomatous polyposis coli (APC) alleles by MALDITOF mass spectrometry[J]. Clinical Biochemistry, 2002,35:87-92.
  • 10Griffin TJ, Smith LM. Single-nucleotide polymorphism analysis by MALDI-TOF mass spect-rometry[J]. Tibtech,2000,18:77 -84.

二级参考文献3

  • 1Tang W Y,Br J Cancer,1999年,81卷,237页
  • 2Ko J M,Cancer Lett,1998年,134卷,169页
  • 3Chiang J W,Cancer Res,1998年,58卷,3289页

共引文献19

同被引文献13

  • 1Cunningham D,Humblet Y,Siena S. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecanrefractory metastatic colorectal cancer[J].New England Journal of Medicine,2004.337-345.
  • 2Lièvre A,Bachet JB,Boige V. KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab[J].Journal of Clinical Oncology,2008,(3):374-379.doi:10.1200/JCO.2007.12.5906.
  • 3Karapetis CS,Khambata-Ford S,Jonker D J. K-ras mutations and benefit from cetuximab in advanced colorectal cancer[J].New England Journal of Medicine,2008.1757-1765.
  • 4Ma ES,Wong CL,Law FB. Detection of KRAS mutations in colorectal cancer by high-resolution melting analysis[J].Journal of Clinical Pathology,2009.886-891.
  • 5Angnlo B,Garcia-Garcia E,Martinez R. A commercial real-time PCR kit provides greater sensitivity than direct sequencing to detect KRAS mutations:a morphology-based approach in colorectal carcinoma[J].Journal of Molecular Diagnostics,2010.292-299.
  • 6Bradi(c) M,Costa J,Chelo IM. Genotyping with Sequenom[J].Methods in Molecular Biology,2011.193-210.
  • 7Yi X,Li J,Yu S. A new PCR-based mass spectrometry system for high-risk HPV,part I methods[J].American Journal of Clinical Pathology,2011.913-919.
  • 8Arcila M,Lau C,Nafa K. Detection of KRAS and BRAF mutations in colorectal carcinoma:roles for highsensitivity locked nucleic acid-PCR sequencing and broadspectrum mass spectrometry genotyping[J].Journal of Molecular Diagnostics,2011.64-73.
  • 9Ehrich M,Deciu C,Zwiefelhofer T. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood:a study in a clinical setting[J].American Journal of Obstetrics and Gynecology,2011.205e1-20e11.
  • 10Sascha S. Typing of single nucleotide polymorphisms by MALDI mass spectrometry:principles and diagnostic applications[J].Clinica Chimica Acta,2006.95-105.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部